New Key Statistics Module, Z-Score and F-Score
OTCPK:LBPWQ Key Ratios
| Market Cap $ M | -- |
| Enterprise Value $ M | -- |
| P/E(ttm) | 9,999.00 |
| PE Ratio without NRI | 9,999.00 |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 6.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -- |
| Beneish M-Score | -5.97 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -7.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -- |
| EV-to-EBITDA | -- |
| PEG | -- |
| Shares Outstanding M | -- |
| Net Margin (%) | -10,337.16 |
| Operating Margin % | -5,082.18 |
| Pre-tax Margin (%) | -11,008.62 |
| Quick Ratio | 5.16 |
| Current Ratio | 5.21 |
| ROA % (ttm) | -128.47 |
| ROE % (ttm) | -204.06 |
| ROIC % (ttm) | -108.40 |
| Dividend Yield % | -- |
| Altman Z-Score | -8.30 |
LBPWQ Number of Guru Trades
LBPWQ Volume of Guru Trades
Gurus Latest Trades with OTCPK:LBPWQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:LBPWQ is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
4d pharma PLC Insider Transactions
No Available Data
News about OTCPK:LBPWQ
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers